Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells. - Wikidata - wikimedia - TriplyDB

Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells.

Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells.

http://www.wikidata.org/entity/Q37184986

about

An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma Induction of epithelial mesenchimal transition and vasculogenesis in the lenses of Dbl oncogene transgenic mice.Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma.Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells.A huge adenosquamous carcinoma of the pancreas with sarcomatoid change: an unusual case report.Gallbladder carcinosarcoma.A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma Molecular mechanisms of cholangiocarcinoma.Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.Joining S100 proteins and migration: for better or for worse, in sickness and in health.S100P is Overexpressed in Squamous Cell and Adenosquamous Carcinoma Subtypes of Endometrial Cancer and Promotes Cancer Cell Proliferation and Invasion.Impact of intracellular ion channels on cancer development and progression.TGF-β Signaling in Gastrointestinal Cancers: Progress in Basic and Clinical Research.Activation of mammalian target of rapamycin complex 1 (mTORC1) and Raf/Pyk2 by growth factor-mediated Eph receptor 2 (EphA2) is required for cholangiocarcinoma growth and metastasis.Silencing of hHS6ST2 inhibits progression of pancreatic cancer through inhibition of Notch signalling.Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.Huge subcapsular hematoma caused by intrahepatic sarcomatoid cholangiocarcinoma.Surgical outcome of carcinosarcoma of the gall bladder: a review.Alterations in the p53-SOCS2 axis contribute to tumor growth in colon cancer.Loss of ezrin in human intrahepatic cholangiocarcinoma is associated with ectopic expression of E-cadherin.

P2860

Q26784091-DE06C7EA-4067-4AEA-894B-AD37FF69EEB1 Q30873811-00137174-D1E1-41EE-BD6F-27449BADE6BC Q33824237-7F8208B4-957F-4A07-90EA-404EB607A3AE Q34355839-CEC74886-7EF5-4AE9-B3B1-95C2D3DB2B0A Q34552257-2329C959-B344-49BB-9941-5ECF052EB4D9 Q34815442-8B477131-E097-493F-886E-28BE24349883 Q35952148-F859A8FD-363A-46C1-B5B4-6A3125EE2850 Q36299705-74F8DE24-40EB-4C91-95F0-5E52125CD26E Q37878879-3794F58E-01B4-4DAE-8058-2291CEE4C65B Q37938716-B11922DF-597D-4180-B3CF-BA0B42AEF725 Q38118075-092D0E5A-BBBA-4040-91FA-399B4CAA8939 Q38727593-87D5F3BC-E0ED-43BD-A95C-C1923D047F63 Q38862322-D4BF6F14-72C4-49F8-9708-69245509F473 Q39096525-0FCFE3A4-9DD1-4F37-BA49-63A3B3371650 Q39211247-EF578AF5-7CCA-4557-A05F-50E5FDBA09C0 Q39569424-2464AE3F-FCA2-4EF4-A49D-CDFF02CED078 Q41173095-257F4873-1608-4B26-A496-8372546FA860 Q42022446-41487A90-BEF6-4C6D-B368-228839C2BC90 Q42588203-F38A2A4A-225D-40D4-BFF5-1D2C6F961DBC Q52721250-AFCE44F2-DD29-43B0-919A-17620BA9985D Q53201713-53AD77F7-38C6-47E4-AD94-9182F09EB9CD

P2860

Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells.

http://www.wikidata.org/entity/Q37184986

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genetic and expression alterat ...... e of cholangiocarcinoma cells.

@en

Genetic and expression alterat ...... e of cholangiocarcinoma cells.

@nl

type

label

Genetic and expression alterat ...... e of cholangiocarcinoma cells.

@en

Genetic and expression alterat ...... e of cholangiocarcinoma cells.

@nl

prefLabel

Genetic and expression alterat ...... e of cholangiocarcinoma cells.

@en

Genetic and expression alterat ...... e of cholangiocarcinoma cells.

@nl

P1433

Q37184986-944B425F-03B7-4BB0-A360-F63C7D847AA7

P1476

Q37184986-979697C5-8A93-48A0-933E-27074888976A

P2093

Q37184986-06936735-1A7E-4930-AE7A-07110B164DF1

Q37184986-19433345-1221-4C60-8AC6-7DEE832185C3

Q37184986-204A94CA-31BC-441C-B5A8-8531092E8128

Q37184986-22926830-DE51-44C1-828A-51F33E9600B2

Q37184986-32926F12-9FD1-4906-97E6-C12BA450E981

Q37184986-34839132-36CE-44D4-9142-AE55F0816991

Q37184986-395E4A64-D08E-480B-864A-1CB9437E5910

Q37184986-6EA119E0-AE98-4988-BB95-73F8EA97970A

Q37184986-A7503DA4-F7EA-4963-85FA-2DC24F585BDA

Q37184986-E2C92479-8E51-43AA-B035-B4ACF16C3A7E

P2860

Q37184986-42ABB27B-8CB2-40C1-B7C7-41D79AD3F005

Q37184986-4BFF8D5A-288D-4AF6-89A4-937DE4BB8F66

Q37184986-5165C2F1-8DEC-48AB-92ED-8620758CB363

Q37184986-66A9B294-1DD0-4CC0-9E05-F27ECE6C9F89

Q37184986-67699E1D-B63E-4D3B-B3FB-90B30DED9651

Q37184986-6E000BAB-2B11-4E15-919B-6C21C87032B1

Q37184986-70D3DA28-6678-4170-9E65-486C93CF8257

Q37184986-97E77020-2FDD-4110-BE44-4667696BB6E8

Q37184986-A76E9497-ADD4-4663-9B74-507CBE10DC97

Q37184986-A7D42148-EE21-4DC6-81CA-E0E24B5DE5C2

P2888

Q37184986-1DD4895B-E321-4ABD-B1AA-B36C8C4E3226

P304

Q37184986-619C9F86-97E1-4A80-BC17-2A42773B0BFF

P31

Q37184986-62395F28-9C3E-45E8-9B3A-BA3A07931291

P356

Q37184986-ACE81D1C-B181-4BAE-94D6-3CA89E83699D

P433

Q37184986-D99BF97D-F54A-4A24-952E-FFC91EE763A8

P478

Q37184986-DA06729F-35BE-42E7-B666-1B89A1A40AE9

P577

Q37184986-CEB688FD-0579-482C-B319-0F6DE4810C59

P5875

Q37184986-34B0F417-FBCB-4DE7-A916-743750B3B510

P6179

Q37184986-35D516A7-C77F-4FAE-BD5A-377B4C1DF983

P698

Q37184986-7733DC63-97E4-4D4F-B9DC-41115874F7CF

P921

Q37184986-03A45205-B331-471B-8BFD-46F2F5F48541

P932

Q37184986-E88B8827-4B69-408E-B2F8-AA43DBE123E0

P356

EMM.2009.41.2.013

P1433

Experimental and Molecular Medicine

P1476

Genetic and expression alterat ...... e of cholangiocarcinoma cells.

@en

P2093

BeeHak Hong

http://www.w3.org/2001/XMLSchema#string

Bo-Ra Yun

http://www.w3.org/2001/XMLSchema#string

Dae-Ghon Kim

http://www.w3.org/2001/XMLSchema#string

Goung-Ran Yu

http://www.w3.org/2001/XMLSchema#string

Hee-Chul Yu

http://www.w3.org/2001/XMLSchema#string

Hee-Jung Yoo

http://www.w3.org/2001/XMLSchema#string

Hyuk-Soo Ahn

http://www.w3.org/2001/XMLSchema#string

Jung-Hee Kwon

http://www.w3.org/2001/XMLSchema#string

KwanYong Choi

http://www.w3.org/2001/XMLSchema#string

Mi-Jin Lee

http://www.w3.org/2001/XMLSchema#string

P2860

The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers

Significance analysis of microarrays applied to the ionizing radiation response

Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/beta-catenin signalling

The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells

Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer.

Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of beta-catenin and upregulation of beta-catenin/lymphoid enhancer binding factor-1 transcriptional activity.

Src and Ras are involved in separate pathways in epithelial cell scattering.

Regulation of the expression of annexin VIII in acute promyelocytic leukemia.

Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior.

P2888

emm.2009.41.2.013

P304

102-115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3858/EMM.2009.41.2.013

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24201725

http://www.w3.org/2001/XMLSchema#string

P6179

1024514576

http://www.w3.org/2001/XMLSchema#string

P698

19287191

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

2679331

http://www.w3.org/2001/XMLSchema#string